About / Media Center
Trinity News
Filter by Type:
Pfizer’s Nurtec, AstraZeneca’s Breztri top pharma brand report
Trinity’s Jerry Luciano and Tim McLaughlin were featured in an article by MM+M titled, “Pfizer’s Nurtec, AstraZeneca’s Breztri top pharma brand report.” The article focuses on the findings of the fourth annual TGaS Digital Marketing Competency Report. Read the article to...
2024 Digital Insights: Pfizer’s Nurtec and AstraZeneca’s Breztri Shine
Trinity Life Sciences’ fourth annual TGaS Digital Marketing Competency Report was featured in an article published on Investors Hangout.
How to achieve a successful drug launch in the first year
Trinity’s Krista Perry, Partner & Head of Launch Excellence, was featured in an article by MM+M titled, “How to achieve a successful drug launch.” Read the article to learn more about what factors contribute to a successful drug launch.
The Challenges and Opportunities in Clinical Trial Diversity: Mistrust in the healthcare system is a significant barrier to recruitment
Trinity’s Lisa Bailey, Ph.D., Managing Director of Insights & Head of DEI Strategy, authored an article that was published in Drug Discovery Today. Read the article, “The Challenges and Opportunities in Clinical Trial Diversity: Mistrust in the healthcare system is a...
Drugs for unmet needs and those from experienced companies had the best chance for successful launches in 2023: report
Trinity’s Krista Perry, Partner & Head of Launch Excellence, was featured in an article by Fierce Pharma to discuss our latest white paper, Moving the Needle: Lessons from the 2023 Launch Class. Read the article to learn more about what factors...
Half of US meds launched in 2023 ‘underperformed’
Trinity Life Sciences’ recent white paper on the first year performance of the 2023 launch class was featured in an article published on The Pharma Letter.
Precision, planning and creativity for launch excellence in a volatile sector
Trinity’s recent white paper, Picking Winners: Portfolio Management for a New Era, was mentioned in a recent article by Pharmaceutical Market Europe.
Big savings? Analyzing the IRA’s impact on the industry
Trinity Life Science’s Monica Martin De Bustamante analyzes the Medicare-negotiated prices of the first 10 drugs under the Inflation Reduction Act.
Finding the Trust in Clinical Trials: Q&A with Lisa Bailey
It’s clear that there is still work to be done with regard to diversity in clinical trials. Lisa Bailey, Managing Director and Head of DEI Strategy at Trinity Life Sciences, shares her insights with Pharmaceutical Executive on the lack of diversity...
This Report Highlights How Companies Can Approach Clinical Trial Diversity
Trinity Life Sciences’ recent white paper on diversity in clinical trials was mentioned in an article published on Black Doctor.
FDA publishes updated draft guidance on clinical trial diversity
Fierce Biotech mentioned Trinity Life Sciences’ recent white paper, Diversity in Clinical Trials: Life Sciences Initiatives and Challenges in Light of the FDA’s Latest Guidance, in their coverage of the updated FDA guidance.
Mistrust in the healthcare system can hold trial diversity back, execs say: report
Trinity Life Sciences’ recent white paper, Diversity in Clinical Trials: Life Sciences Initiatives and Challenges in Light of the FDA’s Latest Guidance, was featured in an article from Fierce Biotech highlighting how mistrust in the healthcare system is holding back trial...